02.09.2022

Advestra advises Gnothis on financing rounds

GNOTHIS HOLD­ING AG, a com­pany act­ive in the health sec­tor, closed two fin­an­cing rounds of nearly CHF 10 mio. this year. Investors include the invest­ment com­pany Nord­stjernan and the indus­tri­al group Hüb­n­er Group. Gnothis is a pion­eer in the devel­op­ment of DNA sequen­cing products with a par­tic­u­lar focus on early can­cer diagnosis.

Advestra advised Gnothis on all leg­al aspects related to the fin­an­cing rounds. The team included Annina Ham­mer, Sandro Fehl­mann and Mar­lon Ber­to­lini (all Cor­por­ate | M&A) and Laurent Ried­weg (Tax).